Helvetia Holding AG (0ACB)
London Exchange · UK · prices in GBP · close of 20 Oct 2026
Key indicators
| Last close | GBP 214.20 |
|---|---|
| 52-week range | 183.73 – 226.60 |
| Return, 1 month / 3 months | −2.5% / −0.8% |
| Return, 1 year / 3 years | +6.2% / +69.3% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 17.8% |
| Worst drawdown (1 year) | -12.9% |
| Average daily value traded | 3.32M GBP |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Helvetia Holding is a Swiss insurance group based in St. Gallen. It offers life and non-life insurance products to individuals and businesses, along with asset management and pension services. Its home market is Switzerland, and it also serves customers in several other European countries, including Germany, Austria, Italy and Spain. The company writes policies covering property, liability, accident, health and retirement needs, and it manages investments on behalf of its policyholders.
Helvetia Holding AG trades under the code 0ACB on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Helvetia Holding AG (0ACB) trades on the London Exchange in UK. It last closed at GBP 214.20 on 20 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 1,046 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.2% and over the last three months it fell 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.4% | ||
| From 52-week high | -4.9% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -0.8% | ||
| 6-month return | -4.4% | ||
| 12-month return, skipping the last month | 8.8% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.9% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.32M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.4% |
|---|---|
| 1 month | −2.5% |
| 3 months | −0.8% |
| 6 months | −4.4% |
| 1 year | +6.2% |
| 3 years | +69.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 211.80 / 207.08 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 3.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 May 2026 | GBX 0.0770 |
| 29 Apr 2025 | GBX 0.0670 |
| 28 May 2024 | GBX 0.0630 |
| 3 May 2023 | GBX 0.0590 |
| 3 May 2022 | GBX 0.0550 |
| 4 May 2021 | GBX 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.